285 related articles for article (PubMed ID: 29112106)
1. Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.
Alayash AI
Shock; 2019 Oct; 52(1S Suppl 1):41-49. PubMed ID: 29112106
[TBL] [Abstract][Full Text] [Related]
2. Blood substitutes: why haven't we been more successful?
Alayash AI
Trends Biotechnol; 2014 Apr; 32(4):177-85. PubMed ID: 24630491
[TBL] [Abstract][Full Text] [Related]
3. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
4. HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.
Cabrales P; Friedman JM
Antioxid Redox Signal; 2013 Jun; 18(17):2284-97. PubMed ID: 23249305
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Biochemical and Biophysical Characterization of Hemoglobin-Based Oxygen Carrier Therapeutics: All HBOCs Are Not Created Equally.
Meng F; Kassa T; Jana S; Wood F; Zhang X; Jia Y; D'Agnillo F; Alayash AI
Bioconjug Chem; 2018 May; 29(5):1560-1575. PubMed ID: 29570272
[TBL] [Abstract][Full Text] [Related]
6. Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.
Benitez Cardenas AS; Samuel PP; Olson JS
Shock; 2019 Oct; 52(1S Suppl 1):28-40. PubMed ID: 29112633
[TBL] [Abstract][Full Text] [Related]
7. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation.
Nagababu E; Ramasamy S; Rifkind JM; Jia Y; Alayash AI
Biochemistry; 2002 Jun; 41(23):7407-15. PubMed ID: 12044174
[TBL] [Abstract][Full Text] [Related]
8. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
Alayash AI; D'Agnillo F; Buehler PW
Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
[TBL] [Abstract][Full Text] [Related]
9. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
Jahr JS; Akha AS; Holtby RJ
Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
[TBL] [Abstract][Full Text] [Related]
10. Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics.
Strader MB; Alayash AI
Antioxid Redox Signal; 2017 May; 26(14):777-793. PubMed ID: 27626360
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.
Simons M; Gretton S; Silkstone GGA; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Leiva-Eriksson N; Ronda L; Mozzarelli A; Strader MB; Alayash AI; Reeder BJ; Cooper CE
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802155
[TBL] [Abstract][Full Text] [Related]
12. Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.
Dorman SC; Kenny CF; Miller L; Hirsch RE; Harrington JP
Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):39-51. PubMed ID: 12000225
[TBL] [Abstract][Full Text] [Related]
13. Adverse HBOC-endothelial dysfunction synergism: a possible contributor to adverse clinical outcomes?
Biro GP
Curr Drug Discov Technol; 2012 Sep; 9(3):194-203. PubMed ID: 21726186
[TBL] [Abstract][Full Text] [Related]
14. Allosteric effects on oxidative and nitrosative reactions of cell-free hemoglobins.
Bonaventura C; Henkens R; Alayash AI; Crumbliss AL
IUBMB Life; 2007; 59(8-9):498-505. PubMed ID: 17701544
[TBL] [Abstract][Full Text] [Related]
15. How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
Samaja M; Malavalli A; Vandegriff KD
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834350
[TBL] [Abstract][Full Text] [Related]
16. Design of recombinant hemoglobins for use in transfusion fluids.
Fronticelli C; Koehler RC
Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
[TBL] [Abstract][Full Text] [Related]
17. Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.
Silkstone GG; Silkstone RS; Wilson MT; Simons M; Bülow L; Kallberg K; Ratanasopa K; Ronda L; Mozzarelli A; Reeder BJ; Cooper CE
Biochem J; 2016 Oct; 473(19):3371-83. PubMed ID: 27470146
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and mechanisms of plasma removal of hemoglobin-based oxygen carriers.
Estep TN
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):203-15. PubMed ID: 26024447
[TBL] [Abstract][Full Text] [Related]
19. From hemoglobin allostery to hemoglobin-based oxygen carriers.
Faggiano S; Ronda L; Bruno S; Abbruzzetti S; Viappiani C; Bettati S; Mozzarelli A
Mol Aspects Med; 2022 Apr; 84():101050. PubMed ID: 34776270
[TBL] [Abstract][Full Text] [Related]
20. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
Jansman MMT; Hosta-Rigau L
Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
